Quest Diagnostics Stock Forecast for 2023 - 2025 - 2030

Updated on 02/27/2024

Stock Rating
10
Price Target
$142.30
Consensus
Outperform
Upside
12.55%
Analysts
8
Stock Rating
10
Upside
12.55%
Analysts
8
Price Target
$142.30

Quest Diagnostics Stock Forecast and Price Target

In recent months, eight notable analysts have provided yearlong price targets for Quest Diagnostics, with the average target coming in at $142.30. If it were to be achieved, this would result in a potential upside of approximately 12.55 percent from the most recent closing price in February, 2024. The high end is $155.00, and the low is $125.00. If you want to buy DGX stock, it might be a good idea to look at its competitors too.

$142.30

12.55% Upside

Outperform
Outperform

Quest Diagnostics Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Quest Diagnostics's Price has fallen from $156.07 to $0.00 – a 100.00% decrease. Next year, analysts are expecting Fair Value to reach $126.20 – an increase of 100.00%. Over the next seven years, the forecast is for Fair Value to grow by 100.00%.

2024 Fair Value Forecast
$126.20
2025 Fair Value Forecast
$140.72
2026 Fair Value Forecast
$150.91
2027 Fair Value Forecast
$160.12
2028 Fair Value Forecast
$401.63
2029 Fair Value Forecast
$304.39
2030 Fair Value Forecast
$269.96
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
LLY Stock Forecast Eli Lilly and Outperform 16
$765.00 Buy/Sell $636.99 3.27%
NOVN Stock Forecast Novartis Outperform 10
CHF90.65 Buy/Sell CHF105.00 21.42%
ROG Stock Forecast Roche Holding Hold 16
CHF231.95 Buy/Sell CHF307.83 16.40%
ABT Stock Forecast Abbott Laboratories Outperform 9
$119.40 Buy/Sell $118.92 5.53%
DHR Stock Forecast Danaher Outperform 10
$254.86 Buy/Sell $260.33 2.02%

Quest Diagnostics Revenue Forecast for 2023 - 2025 - 2030

In the last three years, Quest Diagnostics's Revenue has fallen from $9.44B to $9.25B – a 1.96% decrease. Next year, analysts are expecting Revenue to reach $9.38B – an increase of 1.43%. Over the next seven years, the forecast is for Revenue to grow by 6.53%.

2024 Rev Forecast
$9.38B
2025 Rev Forecast
$10.03B
2026 Rev Forecast
$10.17B
2027 Rev Forecast
$9.57B
2028 Rev Forecast
$9.52B
2029 Rev Forecast
$9.69B
2030 Rev Forecast
$9.86B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
PFE Stock Forecast Pfizer Outperform 2
$26.89 Buy/Sell $32.87 15.28%
GSK Stock Forecast GSK Outperform 12
£16.71 Buy/Sell £17.30 10.11%
BDX Stock Forecast Becton Dickinson and Co Outperform 9
$241.24 Buy/Sell $284.47 16.07%

Quest Diagnostics Dividend per Share Forecast for 2023 - 2025 - 2030

In the last three years, Quest Diagnostics's Dividend per Share has grown by 26.79%, rising from $2.24 to $2.84. In the following year, 7 experts forecast Quest Diagnostics's Dividend per Share will decrease by 4.93%, to $2.70. In 2030, professionals predict that Quest Diagnostics's Dividend per Share will decrease by 4.33%, to $2.72.

2024 DPS Forecast
$2.70
2025 DPS Forecast
$2.61
2026 DPS Forecast
$2.67
2027 DPS Forecast
$2.85
2028 DPS Forecast
$2.80
2029 DPS Forecast
$2.74
2030 DPS Forecast
$2.72
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
4568 Stock Forecast Daiichi Sankyo Company Buy 4
¥5.14k Buy/Sell ¥5.24k 9.03%
IQV Stock Forecast IQVIA Holdings Outperform 15
$248.84 Buy/Sell $267.27 10.51%
BAYN Stock Forecast Bayer Hold 5
29.14€ Buy/Sell 45.15€ 44.13%

Quest Diagnostics Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
$1.25B
2025 FCF Forecast
$1.47B
2026 FCF Forecast
$1.55B
2027 FCF Forecast
$1.37B
2028 FCF Forecast
$1.31B
2029 FCF Forecast
$1.36B
2030 FCF Forecast
$1.43B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ICLR Stock Forecast ICON Public Buy 16
$322.46 Buy/Sell $306.07 9.32%
7751 Stock Forecast Canon Hold 18
¥4.28k Buy/Sell ¥3.74k -11.24%
ILMN Stock Forecast Illumina Outperform 16
$139.76 Buy/Sell $159.28 7.33%

Quest Diagnostics EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Quest Diagnostics's EBITDA has gone down from $2.47B to $1.74B – a 29.34% drop. In the next year, analysts believe that EBITDA will reach $1.88B – an increase of 8.07%. For the next seven years, the forecast is for EBITDA to grow by 9.51%.

2024 EBITDA Forecast
$1.88B
2025 EBITDA Forecast
$1.79B
2026 EBITDA Forecast
$1.99B
2027 EBITDA Forecast
$1.91B
2028 EBITDA Forecast
$1.91B
2029 EBITDA Forecast
$1.87B
2030 EBITDA Forecast
$1.91B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
LH Stock Forecast Laboratory Corp of America Hol... Outperform 11
$215.69 Buy/Sell $241.28 12.66%
HOLX Stock Forecast Hologic Outperform 8
$75.36 Buy/Sell $81.06 8.94%
BVI Stock Forecast Bureau Veritas Outperform 18
26.80€ Buy/Sell 26.96€ 4.48%

Quest Diagnostics EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Quest Diagnostics's EBIT has fallen from $2.11B to $1.31B – a 38.06% decrease. In the next year, analysts believe that EBIT will reach $1.48B – an increase of 13.66%. For the next seven years, experts predict that Quest Diagnostics's EBIT will grow at a rate of 50.45%.

2024 EBIT Forecast
$1.48B
2025 EBIT Forecast
$1.88B
2026 EBIT Forecast
$1.94B
2027 EBIT Forecast
$1.72B
2028 EBIT Forecast
$1.82B
2029 EBIT Forecast
$1.96B
2030 EBIT Forecast
$1.96B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BIM Stock Forecast bioMérieux Outperform 18
103.50€ Buy/Sell 105.55€ 6.28%
CRL Stock Forecast Charles River Laboratories Int... Outperform 16
$252.95 Buy/Sell $229.97 3.78%
ERF Stock Forecast Eurofins Scientific Hold 18
54.74€ Buy/Sell 0.00€ 0.47%

Quest Diagnostics EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, Quest Diagnostics's EPS has fallen from $11.18 to $0.00 – a 100.00% decrease. Next year, analysts are expecting EPS to reach $9.04 – an increase of 100.00%. Over the next seven years, the forecast is for EPS to grow by 100.00%.

2024 EPS Forecast
$9.04
2025 EPS Forecast
$10.08
2026 EPS Forecast
$10.81
2027 EPS Forecast
$11.47
2028 EPS Forecast
$28.77
2029 EPS Forecast
$21.80
2030 EPS Forecast
$19.34
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
4523 Stock Forecast Eisai Outperform 18
¥6.24k Buy/Sell ¥9.58k 35.37%
BRKR Stock Forecast Bruker Outperform 16
$83.70 Buy/Sell $73.64 7.53%
APOLLOHOSP Stock Forecast Apollo Hospitals Enterprise Outperform 18
Rp6.62k Buy/Sell Rp6.91k 8.61%